Variantyx nabs $41.1M for tech-backed genomic analysis
The company plans to use the funds to focus on the oncology space.
Source: mobihealthnews.com
Stay updated with breaking news from Haim Neerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company plans to use the funds to focus on the oncology space.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!